Case number 1:21-cv-00316
Otsuka Pharmaceutical Co., Ltd. et al v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 12, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 525 in lead case no. 19-1938-LPS). (ntl) |
| Jul 12, 2022 | 11 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (10 in 1:21-cv-00316-LPS, 310 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice and Regarding Consolidation filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 9/8/21. Associated Cases: 1:19-cv-01938-LPS, 1:21-cv-00316-LPS (ntl) |
| Sep 8, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Sep 2, 2021 | 10 | Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Jun 1, 2021 | 8 | Answer to Complaint (13) Docket Text: ANSWER to [1] Complaint, by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth) |
| Jun 1, 2021 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Dorsney, Kenneth) |
| May 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION Regarding Waiver of Service and Establishment of Answer Deadlines filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 5/3/21. (ntl) |
| Apr 29, 2021 | 7 | Stipulation (2) Docket Text: STIPULATION Regarding Waiver of Service and Establishment of Answer Deadlines, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Mar 3, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Mar 2, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Mar 1, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3554859.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(myr) |
| Mar 1, 2021 | 1 | Exhibit A-C (62) |
| Mar 1, 2021 | 1 | Civil Cover Sheet (5) |
| Mar 1, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Mar 1, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 18, 2021. Date of Expiration of Patent: December 23, 2028.Thirty Month Stay Deadline: 1/10/2023. (myr) |
| Mar 1, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (myr) |
| Mar 1, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (myr) |
| Mar 1, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (myr) |
